Holen Sie sich die Stockscreener-App
0.6771
2.90%
-0.0202
Handel nachbörslich:
.68
0.0029
+0.43%
Schlusskurs vom Vortag:
$0.6973
Offen:
$0.7
24-Stunden-Volumen:
7.54M
Relative Volume:
0.35
Marktkapitalisierung:
$67.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.89M
KGV:
-0.2676
EPS:
-2.53
Netto-Cashflow:
$-11.95M
1W Leistung:
-23.88%
1M Leistung:
+51.37%
6M Leistung:
-9.72%
1J Leistung:
-50.58%
1-Tages-Spanne:
$0.6602
$0.71
1-Wochen-Bereich:
$0.65
$0.859
52-Wochen-Spanne:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
Firmenname
Plus Therapeutics Inc
Sektor
Branche
Telefon
737.255.7194
Adresse
4200 MARATHON BLVD., AUSTIN, TX
Vergleichen Sie PSTV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.6771 | 69.22M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2025-03-17 | Eingeleitet | D. Boral Capital | Buy |
| 2021-01-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-16 | Eingeleitet | Maxim Group | Buy |
Plus Therapeutics Inc Aktie (PSTV) Neueste Nachrichten
Order flow analysis tools used on Plus Therapeutics Inc.New Guidance & Accurate Buy Signal Notifications - newser.com
Real time scanner hits for Plus Therapeutics Inc. explainedJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Plus Therapeutics Inc. stock outlook for YEARJuly 2025 Retail & Reliable Price Breakout Alerts - newser.com
Why Plus Therapeutics Inc. stock remains on watchlists2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com
What momentum shifts mean for Plus Therapeutics Inc.Dip Buying & Daily Price Action Insights - newser.com
Heatmap analysis for Plus Therapeutics Inc. and competitors2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Multi factor analysis applied to Plus Therapeutics Inc.IPO Watch & Weekly High Return Stock Opportunities - newser.com
What MACD and RSI say about Plus Therapeutics Inc.Gold Moves & Short-Term Swing Trade Alerts - newser.com
Is Plus Therapeutics Inc. stock entering bullish territoryJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Using Ichimoku Cloud for Plus Therapeutics Inc. technicalsJuly 2025 Price Swings & Reliable Price Breakout Signals - newser.com
Will Plus Therapeutics Inc. stock outperform tech sector in 20252025 Short Interest & Real-Time Chart Pattern Alerts - newser.com
Plus Therapeutics' (PSTV) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Top chart patterns to watch in Plus Therapeutics Inc.July 2025 Volume & AI Driven Stock Reports - newser.com
What machine learning models say about Plus Therapeutics Inc.2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Can trapped investors hope for a rebound in Plus Therapeutics Inc.Earnings Growth Summary & Accurate Entry/Exit Alerts - newser.com
Using data models to predict Plus Therapeutics Inc. stock movement2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
How Plus Therapeutics Inc. (XMP0) stock compares with tech leadersTrade Analysis Report & Verified Swing Trading Watchlists - newser.com
How to monitor Plus Therapeutics Inc. with trend dashboardsQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Is Plus Therapeutics Inc a good long term investmentEarnings Season Recap & Small Entry Cost Stocks - earlytimes.in
Plus Therapeutics, Inc. (NASDAQ:PSTV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Plus Therapeutics (NASDAQ:PSTV) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst Says - MarketBeat
Ascendiant Capital Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
Plus Therapeutics (PSTV) Price Target Raised by Ascendiant Capital | PSTV Stock News - GuruFocus
Identifying reversal signals in Plus Therapeutics Inc.Weekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Can Plus Therapeutics Inc. (XMP0) stock double in coming yearsFed Meeting & Fast Gain Stock Tips - newser.com
Why Plus Therapeutics Inc. (XMP0) stock attracts HNW investorsEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Using Bollinger Bands to evaluate Plus Therapeutics Inc.Entry Point & Weekly Breakout Opportunity Watchlist - newser.com
Is it too late to sell Plus Therapeutics Inc.Market Activity Recap & Proven Capital Preservation Tips - newser.com
Plus Therapeutics Stock (PSTV) Opinions on UnitedHealthcare Coverage Deal - Quiver Quantitative
How to interpret RSI for Plus Therapeutics Inc. stock2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-03 00:59:32 - newser.com
What technical patterns form on Plus Therapeutics Inc. (XMP0) stock chartsTrade Risk Report & Safe Entry Trade Signal Reports - newser.com
Finanzdaten der Plus Therapeutics Inc-Aktie (PSTV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):